WEST PHARMACEUTICAL SERVICES
WSTNYSETrading Snapshot
- Day Range
- $370.86 β $382.70
- 52-Week Range
- $223.83 β $386.00
- Volume
- $3.15B
- Avg Volume
- $2.65B
- Shares Outstanding
- 70.4M
- Next Earnings
- Nov 28, 2026
Fundamentals Snapshot
- Annual Revenue
- $3.07B
- Last Q Revenue
- $872M
- P/E Ratio
- 47.1
- P/S Ratio
- 7.8x
- EPS (TTM)
- $7.98
- Dividend Yield
- 0.24%
- Dilution (1yr)
- β1.4%
Why Investors Own WST
- βHigh-growth profile β revenue up -3.0% YoY with expanding US Equity exposure.
- βHealthy economics β 55% gross margin and 29% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
WEST PHARMACEUTICAL SERVICES
WSTAbout WEST PHARMACEUTICAL SERVICES
West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith β a cyclic olefin polymer used in vials, syringes, and cartridges β and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Ratings
βLatest News & Updates

Reasons to Add West Pharmaceutical Stock to Your Portfolio Now
West Pharmaceutical's biologics exposure, Annex 1 projects and delivery-device growth support prospects despite near-term headwinds.

West Pharmaceutical Services, Inc. (WST) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
West Pharmaceutical Services, Inc. (WST) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

West Pharmaceutical Services, Inc. (WST) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
West Pharmaceutical Services, Inc. (WST) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

West Pharmaceutical Services, Inc. $WST Shares Sold by HB Wealth Management LLC
HB Wealth Management LLC lowered its stake in shares of West Pharmaceutical Services, Inc. (NYSE: WST) by 28.3% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC)

Analyzing West Pharmaceutical Services (NYSE:WST) and Acutus Medical (NASDAQ:AFIB)
West Pharmaceutical Services (NYSE: WST - Get Free Report) and Acutus Medical (NASDAQ: AFIB - Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the two companies based o

Benjamin Edwards Inc. Grows Position in West Pharmaceutical Services, Inc. $WST
Benjamin Edwards Inc. grew its stake in West Pharmaceutical Services, Inc. (NYSE: WST) by 47.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commissi